Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,314.00
-10.10 (-0.76%)
Oct 21, 2026, 3:29 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.06 trillion as of October 21, 2026. It is the 1,956th most valuable company in the world and the 98th biggest in India. Its market cap has decreased by 19.83% in one year.
Market Cap
1.06T
Enterprise Value
968.25B
Revenue
280.68B
Global Rank
Country Rank
#98 India
PE Ratio
31.51
ChartMarket Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.06T, an increase of 70,027.07%. That is a compound annual growth rate of 24.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 1.06T | -13.05% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.44T |
| Zydus Lifesciences | 1.11T |
| Laurus Labs | 1.09T |
| Mankind Pharma | 943.90B |
| Aurobindo Pharma | 908.41B |
| Glenmark Pharmaceuticals | 619.18B |
| Alkem Laboratories | 599.62B |
| Ipca Laboratories | 486.83B |